Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Multiple Myeloma 107Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Recurrence 20Leukemia 18Burkitt Lymphoma 18Lymphoma 17Neoplasms, Plasma Cell 13Lymphoma, Non-Hodgkin 13Nausea 12Lymphoma, Mantle-Cell 12Vomiting 11Waldenstrom Macroglobulinemia 10Breast Neoplasms 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Neoplasms 9Lymphoma, Follicular 9Immunoglobulin Light-chain Amyloidosis 8Lymphoma, B-Cell, Marginal Zone 7Hodgkin Disease 7Amyloidosis 7Smoldering Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Prostatic Neoplasms 5Leukemia, Biphenotypic, Acute 5Hematologic Neoplasms 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4

Interventions

pembrolizumab 120Cisplatin 26Carboplatin 24Paclitaxel 21Docetaxel 17lenvatinib 15Pemetrexed 12Fluorouracil 12Saline Solution 11Capecitabine 10epacadostat 8Oxaliplatin 7Gemcitabine 7Leucovorin 5Cetuximab 5130-nm albumin-bound paclitaxel 5olaparib 4enzalutamide 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4trifluridine tipiracil drug combination 3regorafenib 3Prednisone 3Dexamethasone 3Radiotherapy 2Ipilimumab 2Glucose 2Etoposide 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Parkinson Disease 4, Autosomal Dominant Lewy Body × Calcium Dobesilate × Clear all
NCT03834506 2025-07-18

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Completed
1,030 enrolled 24 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡